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OBJECTIVE: To assess the presence of metabolic disorders in elderly men with urolithiasis.
METHODS:We performed a case-control study. The inclusion criteria were as follows: (1) men older than 60 years of
age and either (2) antecedent renal colic or an incidental diagnosis of urinary lithiasis after age 60 (case arm) or (3)
no antecedent renal colic or incidental diagnosis of urolithiasis (control arm). Each individual underwent an
interview, and those who were selected underwent all clinical protocol examinations: serum levels of total and
ionized calcium, uric acid, phosphorus, glucose, urea, creatinine and parathyroid hormone, urine culture, and
analysis of 24-hour urine samples (levels of calcium, citrate, creatinine, uric acid and sodium, pH and urine volume).
Each case arm patient underwent two complete metabolic urinary investigations, whereas each control arm
individual underwent one examination. ClinicalTrials.gov: NCT01246531.
RESULTS: A total of 51 subjects completed the clinical investigation: 25 in the case arm and 26 in the control arm. In
total, 56% of the case arm patients had hypocitraturia (vs. 15.4% in the control arm; p=0.002). Hypernatriuria was
detected in 64% of the case arm patients and in 30.8% of the controls (p=0.017).
CONCLUSION: Hypocitraturia and hypernatriuria are the main metabolic disorders in elderly men with urolithiasis.
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INTRODUCTION
The increase in male life expectancy has provoked many
inquiries into health disorders and quality of life with
respect to the natural aging process. Populational aging is
characterized by a higher proportion of people who reach
advanced ages combined with shrinking numbers of
children and young people in that group. According to
the World Health Organization (WHO), aging is defined as
living beyond 60 years in a developing country or 65 years
in a developed country. The number of aging people is
increasing faster than is any other age group: in 2025, there
will be an estimated 1.2 billion individuals over the age of
60, and this number could reach two billion by 2050 (1).
Urolithiasis is a public health problem affecting approxi-
mately 300 men and 100 women out of every 100,000 people
(2). At present, the incidence of urolithiasis in aging people
is increasingly, particularly in industrialized countries (3-5).
Little information is available about urolithiasis in older
individuals, especially with respect to metabolic disorders
that may be helpful for the clinical treatment of these
individuals.
MATERIALS AND METHODS
This project was approved by our Hospital Ethics
Committee (protocol number 0688/07) in October 2007. It
was also registered in Clinical Trials (www.clinicaltrials.
gov): NCT01246531. All patients provided written informed
consent for their participation in the study. We performed a
case-control study with patients who were recruited from a
database of the Urologic Clinic between January 2008 and
January 2010.
The inclusion criteria for the case arm were applied to
patients from the Urinary Lithiasis database: (I) men older
than 60 years of age (II) who had a first episode of renal
colic (lumbar or flank pain) or an incidental diagnosis of
renal stones after age 60. The patients in the control arm
were selected from a database of men with benign prostate
hyperplasia (BPH). The inclusion criteria were as follows:
(I) men older than 60 years of age and (II) with no
diagnosis of renal stones at any point in their lives. All
patients were asked about their stone disease history (renal
colic, age at the first lithiasic episode, incidental urolithiasis
diagnosis, antecedent shockwave lithotripsy or surgical
therapies for renal and/or ureteral calculi), persistent
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urinary tract infection, family history of renal stones,
clinical comorbidities (e.g., hypertension, diabetes, dyslipi-
demia, gout) and drug use (including alcohol consumption
and smoking). All subjects underwent the following
metabolic assessments:
N Blood tests: total calcium, ionized calcium, uric acid,
phosphorus, glucose, creatinine, urea and parathyroid
hormone (PTH) levels;
N Type I urinalysis and urine culture;
N 24-hour urine samples: calcium, citrate, creatinine, uric
acid and sodium levels, pH and volume.
Each case arm patient underwent two complete metabolic
urinary investigations, and the control arm patients under-
went one metabolic urinary investigation with three 24-hour
urinary samples, as described previously.
Imaging examinations, including abdominal X-rays,
abdominal ultrasonography, and unenhanced abdominal
computed tomography (CT) (if necessary), were conducted
for documentation purposes.
Frequency analyses and descriptive statistics i.e., mean and
standard deviation (SD), were performed. The Student’s t-
test was used to compare the case and control arms. The
associations between the independent data from the case and
control arms were tested using the chi-squared test. If the
expected value in any category was less than or equal to five,
Fisher’s exact test was performed instead of the chi-squared
test. Independent variables that demonstrated statistically
significant differences were tested by univariate logistic
regression analyses. Multiple logistic regression analysis
evaluated the relationship between hypocitraturia and
hypernatriuria, adjusting for thiazide use based on our
theoretical understanding of the effects of thiazide diuretics
on renal metabolism (6). Statistical significance was set at
p,0.05. All statistical analyses were conducted using SPSS
for Windows 18.0 software (Chicago, IL).
RESULTS
After applying the inclusion criteria, 70 patients were
selected to participate in the clinical protocol. Nineteen
patients did not complete the clinical study, with seventeen
lost to follow-up (eight patients from the case arm and nine
from the control arm). Two individuals were diagnosed
with prostate cancer during the study and were discharged
for oncologic management (one from each arm). In total, 51
men completed the protocol: 25 in the case arm and 26 in the
control arm.
The two groups were statistically comparable in terms of
their demographics, comorbidities, smoking and alcoholic
beverage consumption habits, and thiazide use (Table 1).
Twenty patients from the case arm had comorbidities:
systemic arterial hypertension (n= 11), diabetes mellitus
(n = 7), and gout (n = 3). In the control arm, there were 21
men with comorbidities: systemic arterial hypertension
(n = 13), diabetes mellitus (n = 4), and gout (n = 1).
The blood metabolic assessments revealed no significant
disorders (Table 2).
The urinary metabolic assessments revealed hypocitra-
turia in 56.0% of the case arm patients and 15.4% of the
control arm patients (p= 0.002). Hypernatriuria was
detected in 64.0% of the case arm patients and in 30.8%
of the controls (p= 0.017). No additional statistically
significant differences were present for the remaining
variables (Table 3). These findings were confirmed by the
univariate analyses and multiple logistic regressions.
Hypocitraturia and elevated urinary sodium levels were
independent risk factors for urinary lithiasis, even when
adjusted for thiazide use (Table 4), which would be
considered a confounding factor in the analysis. Another
notable observation was the presence of an altered urinary
pH in 11 patients of the case arm compared with five
individuals from the control arm, a difference that
approached statistical significance (p= 0.057).
Table 1 - Demographics, comorbidities, smoking and alcohol consumption habits and thiazide use.
Variable Cases Controls p-value
x (SD) x (SD)
Age (years) 68.3 (5.4) 67.8 (5.9) 0.750*
(60 – 78) (60 – 83)
Weight (kg) 79.2 (11.7) 74.9 (11.0) 0.177*
(59 – 103) (60 – 100)
n (%) n (%) p
Race
Caucasian 22 (88.0) 24 (92.3) 0.668{
Non-Caucasian 3 (12.0) 2 (7.7)
Alcohol consumption
No 17 (68.0) 20 (76.9) 0.475
Yes 8 (32.0) 6 (23.1)
Smoker
No 23 (92.0) 21 (80.8) 0.419{
Yes 2 (8.0) 5 (19.2)
Medical disorders
No 5 (20.0) 6 (23.1) 0.789
Yes 20 (80.0) 20 (76.9)
Thiazide use
No 22 (88.0) 20 (76.9) 0.465{
Yes 3 (12.0) 6 (23.1)
Total 25 (100) 26 (100)
*Student’s T-test; {Fisher’s exact test; SD= standard deviation.
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DISCUSSION
Urinary lithiasis in elderly people has an estimated
prevalence of 10–12% and an estimated incidence of 0.1–2%
(7). In Japan, the prevalence reaches almost 9.6% and
predominantly affects men (71.7%) (8). No consensus exists
on the worldwide prevalence of urolithiasis in aging
individuals, and even given the recent increase in incidence,
there are few studies on this subject in the urological literature.
Urolithiasis is a disorder that may cause a higher
morbidity rate in older people than in younger people,
mainly due to urinary obstruction related to stone migration
and infectious complications (9). Recently, some authors
have assessed the aspects and outcomes of extracorporeal
shock wave lithotripsy (SWL) (10-14), percutaneous nephro-
lithotomy (15-17) and ureteroscopy (18) for elderly patients
with renal or ureteral stones. However, no recent studies
have involved metabolic assessments of urinary lithiasis in
aging subjects.
We performed a case-control study that was initially
designed as a pilot study with 70 patients. Unfortunately,
we lost almost 25% of our sample, which is higher than the
normal attrition rate of 10% reported in a majority of
studies. Most patients who stopped the study cited the 24-
hour urine gathering protocol and transportation to the
clinical laboratory as their main reasons for withdrawal. A
case-control study design was selected because the sample
size was small (because urinary lithiasis is not common in
aging people) and no comparative studies existed on
metabolic assessments in aging men with urolithiasis.
Another advantage of the case-control design is its ability
to evaluate the feasibility of more complex and expensive
future projects.
The control arm did include individuals with BPH, which
could have introduced possible selection bias (e.g., limited
fluid intake due to nocturia and/or urinary frequency).
Patients from the control arm presented with higher urinary
volumes than did those in the case arm: 80.8% vs. 70.8%,
although this difference was not significant.
We did not include women in this study because of the
potential effects of postmenopausal physiology and hormo-
nal replacement therapy (HRT), which could produce
questionable outcomes in the metabolic assessments.
Maalouf et al. investigated 25,000 postmenopausal women
and documented an association between hormonal replace-
ment therapy and the development of urinary lithiasis (19),
which was mediated by exacerbated calcitriol production
(an estrogenic effect) leading to an increase in the intestinal
absorption of calcium. Another clinical study assessing
women undergoing HRT over the course of ten years found
no increase in urinary lithiasis events (20).
None of the patients had undergone gastric bypass
surgery, another potential cause of hyperoxaluria, which
could have resulted in confounding. All individuals from
the case arm were asymptomatic during the study, and
radiologic examinations did not reveal any obstructive
Table 2 - Metabolic assessment (blood tests).
Variable Cases Controls p-value
n (%) n %
Total calcium
(RV: 8.6 – 10.2 mg/dl)
Normal 22 (88.0) 25 (96.2) 0.350{
High 3 (12.0) 1 (3.8)
Ionized calcium
(RV: 4.6 – 5.3 mg/dl)
Normal 22 (88.0) 24 (92.4) 0.668{
High 3 (12.0) 2 (7.7)
Uric acid
(RV: 3.4 – 7.0 mg/dl)
Normal 20 (80.0) 20 (76.9) 0.789*
High 5 (20) 6 (23.1)
Phosphorus
(RV: 2.7 – 4.5 mg/dl)
Normal 20 (80.0) 20 (76.9) 0.789*
Low 5 (20.0) 6 (23.1)
Glucose
(RV: 65 – 99 mg/dl)
Normal 10 (40.0) 9 (34.6) 0.691*
High 16 (60.0) 17 (65.4)
Urea
(RV: 10 – 50 mg/dl)
Normal 22 (88.0) 25 (96.2) 0.350{
High 3 (12.0) 1 (3.8)
Creatinine
(RV: 0.6 – 1.5 mg/dl)
Normal 23 (92.0) 25 (96.2) 0.610{
High 2 (8.0) 1 (3.8)
PTH
(RV: 16 – 87 pg/dl)
Normal 22 (88.0) 18 (69.2) 0.103*
High 3 (12.0) 8 (30.8)
Total 25 (100) 26 (100)
RV= reference value.
Table 3 - Metabolic assessment: 24-hour urine samples
and urine culture.
Variable cases Controls p-value
n (%) n %
Calcium
(RV: 100 – 240 mg)
Normal 22 (88.0) 18 (69.2) 0.103*
High 3 (12.0) 8 (30.8)
Citrate
(RV: . 290 mg)
Normal 11 (44.0) 22 (84.6) 0.002*
Low 14 (56.0) 4 (15.4)
Creatinine
(RV: 1.04 – 2.35 g)
Normal 25 (100) 26 (100)
High 0 (--) 0 (--)
Sodium
(RV: 40 – 220 mEq)
Normal 9 (36.0) 18 (69.2) 0.017*
High 16 (64.0) 8 (30.8)
Uric acid
(RV: 0.2 – 0.75 g)
Normal 20 (80.0) 23 (85.5) 0.465{
High 5 (20.0) 3 (11.5)
Volume 24 hours
(RV: .or = 20 ml/kg/day)
Normal 17 (70.8) 21 (80.8) 0.411*
Low 7 (29.2) 5 (19.5)
pH
(RV: 6 – 7)
Normal 14 (56.0) 21 (80.8) 0.057*
Altered 11 (44.0) 5 (19.2)
Urine culture
(RV: Negative)
Negative 23 (92.0) 22 (84.6) 0.668{
Positive 2 (8.0) 4 (15.4)
Total 25 (100) 26 (100)
RV= reference value; *Chi-square test; {Fisher’s exact test.
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ureteral calculi or other complication(s) or sign(s) of
urolithiasis.
Despite the theoretical importance of some comorbidities
in the pathophysiology of nephrolithiasis, the small sample
size did not allow us to draw any conclusions on these kinds
of associations. However, no significant differences were
observed between the cases and controls in terms of the
occurrence of comorbidities.
Hypocitraturia and hypernatriuria were the main meta-
bolic disorders identified in our study. Urinary citrate is an
important inhibitor of calcium oxalate/phosphate lithogen-
esis. The prevalence of hypocitraturia has been estimated at
20–50%, mostly in association with other metabolic dis-
orders (21). No established data exist on the prevalence of
hypocitraturia in aging people with urolithiasis. In a
retrospective study, Usui et al. found that 5% of the subjects
had low urinary citrate levels, but they did not exclude
subjects with a prior urolithiasis diagnosis before the age of
60 (8). In another retrospective study, Gentle et al. found
that 29% of elderly individuals were hypocitraturic, and
40% of these individuals were first diagnosed with urinary
lithiasis before the age of 50. In both studies, the authors
were most likely analyzing chronic stone-formers who had
had this condition since their third and fourth decades of
life in addition to individuals who started having symptoms
after 60 years of age (22). One explanation for the
predominance of hypocitraturia in this age group could be
specific dietary habits, including high protein and salt
intake. The resultant acidotic state would promote low
urinary citrate excretion through proximal convoluted
tubule reabsorption, balancing the intracellular pH (23).
Another consequence of acidosis is bone calcium mobiliza-
tion with transitory hypercalciuria, which increases the
lithogenic risk of developing calcium kidney stones (24,25).
High levels of urinary sodium reduce calcium reabsorp-
tion via the proximal convoluted tubules, promoting mild
systemic acidosis that increases the risk of calcium
lithogenesis (26). An association often exists between high
salt intake and hypocitraturia because of the resulting
acidotic state (27). We identified nine patients in the case
arm with hypocitraturia associated with hypernatriuria, as
suggested above. The ingestion of a sodium rich diet plays
an important role in the formation of calcium oxalate stones,
and this association may also explain the high occurrence of
hypernatriuria in the case arm patients.
The hypercalciuria levels did not differ between the case
and control arms. Hypercalciuria is the most common
metabolic disorder in chronic stone-formers (approximately
60%) (28). The low occurrence of hypercalciuria serves
as additional evidence that aging people have distinct
pathophysiological features compared with younger sub-
jects, including features related to urinary lithiasis.
Our study has several limitations. First, we did not
analyze urinary oxalate levels in the 24-hour urine samples
because it is not a standardized test in our clinical
laboratory. Taylor et al. performed a retrospective study
based on three cohorts, totaling 3,348 subjects and including
both urolithiasis formers and non-formers (29), to evaluate
the relationship between dietary oxalate and urinary
oxalate. Diabetics and obese people presented with high
levels of urinary oxalate, but an assessment of the age factor
revealed that the older the individual, the more minor his/
her urinary oxalate levels; in other words, an inversely
proportional relationship exists between age and urinary
oxalate levels (29).
The association between urolithiasis and the metabolic
syndrome was not approached in this study. At the time of
the conception of this study, that association had not yet
well established. However, the metabolic syndrome in
patients with urolithiasis seems to be more common in
aging individuals than in younger individuals (30).
In conclusion, hypocitraturia and hypernatriuria are the
main metabolic disorders found in aging men with
urolithiasis.
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